Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Debt / NOTE 1.250% 5/1
-
Market price (% of par)
-
104.3%
-
Total 13F principal
-
$332,555,033
-
Principal change
-
+$75,292,859
-
Total reported market value
-
$347,197,165
-
Number of holders
-
44
-
Value change
-
+$77,647,985
-
Number of buys
-
22
-
Number of sells
-
17
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 as of Q1 2023
As of 31 Mar 2023,
BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 was held by
44 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$332,555,033
in principal (par value) of the bond.
The largest 10 bondholders included
Voya Investment Management LLC, MACKAY SHIELDS LLC, LAZARD ASSET MANAGEMENT LLC, Wellesley Asset Management, ADVENT CAPITAL MANAGEMENT /DE/, Thrivent Financial for Lutherans, Lombard Odier Asset Management (Europe) Ltd, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main, STATE STREET CORP, and Invesco Ltd..
This page lists
45
institutional bondholders reporting positions
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.